Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
An update from Amoeba SA ( (FR:ALMIB) ) is now available.
Amoéba has announced the initiation of stock coverage by Euroland Corporate, with a Buy recommendation and a target price of €2.40 per share. This represents a potential upside of over 150% compared to the previous closing price, signaling confidence in the company’s market prospects and future growth potential. This development is likely to enhance Amoéba’s visibility in the financial markets and could positively impact its industry positioning and stakeholder engagement.
More about Amoeba SA
Amoéba is a greentech company based in Chassieu, Lyon, France, founded in 2010. It specializes in the development of natural microbiological solutions using patented amoebae technology, targeting the plant protection and cosmetics sectors. The company aims to offer sustainable biological alternatives to chemical products and has secured regulatory approvals in the USA and Europe for its plant protection solutions. Amoéba is listed on Euronext Growth and is part of the Bpifrance Excellence network.
YTD Price Performance: -11.51%
Average Trading Volume: 1,463
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €44.69M
For an in-depth examination of ALMIB stock, go to TipRanks’ Stock Analysis page.
